Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Institut für Pathologie, Universität Bern, Bern, Switzerland.
Histopathology. 2019 Mar;74(4):629-637. doi: 10.1111/his.13768. Epub 2019 Jan 15.
The Oxford Classification E score (endocapillary hypercellularity) predicts renal functional decline in IgA nephropathy (IgAN) patients free from steroid/immunosuppressive (IS) therapy, but is poorly reproducible. We hypothesise that endocapillary hypercellularity reflects glomerular inflammation and that the presence of CD68-positive cells is a more robust marker of E score.
CD68-positive cells were quantified in glomeruli and tubulointerstitium in biopsies from 118 IgAN patients, and cell counts were correlated with the criteria of the Oxford Classification, assigned on PAS-stained serial sections. There was a strong correlation between median glomerular CD68 count and the percentage of glomeruli showing endocapillary hypercellularity (r = 0.67; P < 0.001; r = 0.45), while there was no correlation between CD68-positive cells and mesangial hypercellularity, % segmental sclerosis, % of crescents and % tubular atrophy/interstitial fibrosis (TA/IF). ROC curve analysis demonstrated that a maximum glomerular CD68 count of 6 is the best cut-off for distinguishing E0 from E1 (sensitivity 94.1%, specificity 71%, area under the curve = 89%). Identification of biopsies with a maximum glomerular CD68-count >6 was reproducible (kappa score 0.8), and there was a strong correlation between glomerular CD68 counts obtained by conventional light microscopy and by image analysis (r = 0.80, r = 0.64, P < 0.0001). Digital image analysis revealed that tubulointerstitial CD68-positive cells correlated moderately with % TA/IF (r = 0.59, r = 0.35, P < 0.001) and GFR at the time of biopsy (r = 0.54, r = 0.29, P < 0.0001), but not with mesangial and endocapillary hypercellularity.
While glomerular CD68-positive cells emerge as markers of endocapillary hypercellularity, their tubulointerstitial counterparts are associated with chronic damage.
牛津分类 E 评分(毛细血管内细胞增生)预测 IgA 肾病(IgAN)患者在无类固醇/免疫抑制剂(IS)治疗时的肾功能下降,但重复性差。我们假设毛细血管内细胞增生反映肾小球炎症,并且 CD68 阳性细胞的存在是 E 评分更可靠的标志物。
在 118 例 IgAN 患者的活检标本中,定量检测了肾小球和肾小管间质中的 CD68 阳性细胞,并将细胞计数与 PAS 染色连续切片上的牛津分类标准进行了相关性分析。中位肾小球 CD68 计数与表现为毛细血管内细胞增生的肾小球百分比之间存在很强的相关性(r=0.67;P<0.001;r=0.45),而 CD68 阳性细胞与系膜细胞增生、节段性硬化、新月体形成和肾小管萎缩/间质纤维化(TA/IF)百分比之间无相关性。ROC 曲线分析表明,最大肾小球 CD68 计数 6 是区分 E0 与 E1 的最佳截断值(敏感性 94.1%,特异性 71%,曲线下面积为 89%)。识别最大肾小球 CD68 计数>6 的活检标本具有可重复性(kappa 评分 0.8),并且通过常规光镜和图像分析获得的肾小球 CD68 计数之间存在很强的相关性(r=0.80,r=0.64,P<0.0001)。数字图像分析显示,肾小管间质 CD68 阳性细胞与 TA/IF 百分比中度相关(r=0.59,r=0.35,P<0.001)和活检时的肾小球滤过率(r=0.54,r=0.29,P<0.0001),但与系膜细胞增生和毛细血管内细胞增生无关。
虽然肾小球 CD68 阳性细胞是毛细血管内细胞增生的标志物,但它们的肾小管间质对应物与慢性损伤有关。